MedTrace Logo

Collaborative Ocular Melanoma Study (COMS)

NCT00000124 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2006-06-02

No results posted yet for this study

Summary

To evaluate therapeutic interventions for patients who have choroidal melanoma, the most common primary eye cancer affecting adults, and to assess the potential life-preserving as well as sight-preserving role of radiation therapy.

To determine which of two standard treatments, removal of the eye or brachytherapy, is more likely to prolong survival of eligible patients with medium-sized choroidal melanoma.

To determine whether preoperative radiation prolongs life for patients whose eyes with large choroidal melanoma are enucleated.

Conditions

  • Choroid Neoplasms
  • Uveitis

Interventions

PROCEDURE

Brachytherapy

PROCEDURE

Eye Removal

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1986-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000124 on ClinicalTrials.gov